Does methylmercury-induced hypercholesterolemia play a causal role in its neurotoxicity and cardiovascular disease?

Toxicological Sciences

Volumn 130, Issue 2, 2012, Pages 373-382

  Moreira, Eduardo Luiz ^a   De oliveira, Jade ^a   Dutra, Márcio Ferreira ^b   Santos, Danúbia Bonfanti ^a   Gonçalves, Carlos Alberto ^b   Goldfeder, Eliane Maria ^a   De bem, Andreza Fabro ^a   Prediger, Rui Daniel ^a   Aschner, Michael ^c,d   Farina, Marcelo ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Cholesterol; Dyslipidemia; Low density lipoprotein receptor; Methylmercury; Neurotoxicity

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLMERCURY; PROBUCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; MOUSE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; RISK FACTOR;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CEREBELLUM; CHOLESTEROL; CHOLESTEROL, LDL; GLUTATHIONE PEROXIDASE; HYPERCHOLESTEROLEMIA; KIDNEY; LIVER; MALE; MERCURY POISONING, NERVOUS SYSTEM; METHYLMERCURY COMPOUNDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEUROGLIA; PROBUCOL; RECEPTORS, LDL; TIME FACTORS; UREA; WATER POLLUTANTS, CHEMICAL;

MUS; RODENTIA;

EID: 84869417613     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs252     Document Type: Article

References (55)

1. Aytan, N., Jung, T., Tamtük, F., Grune, T., and Kartal-Ozer, N. (2008). Oxidative stress related changes in the brain of hypercholesterolemic rabbits. Biofactors 33, 225-236.
2. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
3. Carvalho, C. M., Chew, E. H., Hashemy, S. I., Lu, J., and Holmgren, A. (2008). Inhibition of the human thioredoxin system. A molecular mechanism of mercury toxicity. J. Biol. Chem. 283, 11913-11923.
4. Choi, A. L., Weihe, P., Budtz-Jögensen, E., Jögensen, P. J., Salonen, J. T., Tuomainen, T. P., Murata, K., Nielsen, H. P., Petersen, M. S., Askham, J., et al. (2009). Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men. Environ. Health Perspect. 117, 367-372.
5. Clarkson, T. W., Magos, L., and Myers, G. J. (2003). The toxicology of mercury- current exposures and clinical manifestations. N. Engl. J. Med. 349, 1731-1737.
6. de Marco, K. C., Passos, C. J., Sertorio, J., Tanus-Santos, J. E., and Barbosa, F. Jr. (2010). Environmental exposure to methylmercury is associated with a decrease in nitric oxide production. Basic Clin. Pharmacol. Toxicol. 106, 411-415.
7. de Oliveira, J., Hort, M. A., Moreira, E. L., Glaser, V., Ribeiro-do-Valle, R. M., Prediger, R. D., Farina, M., Latini, A., and de Bem, A. F. (2011). Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: Relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress. Neuroscience 197, 99-106.
8. Dietrich, M. O., Mantese, C. E., Anjos, G. D., Souza, D. O., and Farina, M. (2005). Motor impairment induced by oral exposure to methylmercury in adult mice. Environ. Toxicol. Pharmacol. 19, 169-175.
9. el-Fawal, H. A., Gong, Z., Little, A. R., and Evans, H. L. (1996). Exposure to methyl mercury results in serum autoantibodies to neurotypic and gliotypic proteins. Neurotoxicology 17, 267-276.
10. Endo, T., and Haraguchi, K. (2010). High mercury levels in hair samples from residents of Taiji, a Japanese whaling town. Mar. Pollut. Bull. 60, 743-747.
11. Eto, K., Yasutake, A., Miyamoto, K., Tokunaga, H., and Otsuka, Y. (1997). Chronic effects of methylmercury in rats. II. Pathological aspects. Tohoku J. Exp. Med. 182, 197-205.
12. Farina, M., Aschner, M., and Rocha, J. B. (2011a). Oxidative stress in MeHg-induced neurotoxicity. Toxicol. Appl. Pharmacol. 256, 405-417.
13. Farina, M., Campos, F., Vendrell, I., Berenguer, J., Barzi, M., Pons, S., and Suñol, C. (2009). Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells. Toxicol. Sci. 112, 416-426.
14. Farina, M., Frizzo, M. E., Soares, F. A., Schwalm, F. D., Dietrich, M. O., Zeni, G., Rocha, J. B., and Souza, D. O. (2003). Ebselen protects against methylmercury-induced inhibition of glutamate uptake by cortical slices from adult mice. Toxicol. Lett. 144, 351-357.
15. Farina, M., Rocha, J. B., and Aschner, M. (2011b). Mechanisms of methylmercury-induced neurotoxicity: Evidence from experimental studies. Life Sci. 89, 555-563.
16. Folch, J., Lees, M., and Sloane Stanley, G. H. (1957). A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509.
17. Franco, J. L., Posser, T., Dunkley, P. R., Dickson, P. W., Mattos, J. J., Martins, R., Bainy, A. C., Marques, M. R., Dafre, A. L., and Farina, M. (2009). Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase. Free Radic. Biol. Med. 47, 449-457.
18. Franco, J. L., Teixeira, A., Meotti, F. C., Ribas, C. M., Stringari, J., Garcia Pomblum, S. C., Moro, A. M., Bohrer, D., Bairros, A. V., Dafre, A. L., Santos, A. R., and Farina, M. (2006). Cerebellar thiol status and motor deficit after lactational exposure to methylmercury. Environ. Res. 102, 22-28.
19. Fujita, T., Nakamura, N., Kumasaka, R., Shimada, M., Murakami, R., Osawa, H., Yamabe, H., and Okumura, K. (2006). Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy. In Vivo 20(6B), 891-893.
20. Garg, A., and Simha, V. (2007). Update on dyslipidemia. J. Clin. Endocrinol. Metab. 92, 1581-1589.
21. Grandjean, P., Murata, K., Budtz-Jørgensen, E., and Weihe, P. (2004). Cardiac autonomic activity in methylmercury neurotoxicity: 14-year follow-up of a Faroese birth cohort. J. Pediatr. 144, 169-176.
22. Greenwood, J., Steinman, L., and Zamvil, S. S. (2006). Statin therapy and autoimmune disease: From protein prenylation to immunomodulation. Nat. Rev. Immunol. 6, 358-370.
23. Hintelmann, H. (2010). Organomercurials. Their formation and pathways in the environment. Met. Ions Life Sci. 7, 365-401.
24. Jin, X., Chan, H. M., Lok, E., Kapal, K., Taylor, M., Kubow, S., and Mehta, R. (2008). Dietary fats modulate methylmercury-mediated systemic oxidative stress and oxidative DNA damage in rats. Food Chem. Toxicol. 46, 1706-1720.
25. Jin, X., Hidiroglou, N., Lok, E., Taylor, M., Kapal, K., Ross, N., Sarafin, K., Lau, A., De Souza, A., Chan, H. M., et al. (2012). Dietary selenium (Se) and vitamin E (V(E)) supplementation modulated methylmercury-mediated changes in markers of cardiovascular diseases in rats. Cardiovasc. Toxicol. 12, 10-24.
26. Jin, X., Lok, E., Caldwell, D., Mueller, R., Kapal, K., Liston, V., Kubow, S., Chan, H. M., and Mehta, R. (2009). Dietary fats altered nephrotoxicity profile of methylmercury in rats. J. Appl. Toxicol. 29, 126-140.
27. Kaur, P., Heggland, I., Aschner, M., and Syversen, T. (2008). Docosahexaenoic acid may act as a neuroprotector for methylmercury-induced neurotoxicity in primary neural cell cultures. Neurotoxicology 29, 978-987.
28. Keane, W. F., Tomassini, J. E., and Neff, D. R. (2011). Lipid abnormalities in patients with chronic kidney disease. Contrib. Nephrol. 171, 135-142.
29. Kielar, M. L., Jeyarajah, D. R., Zhou, X. J., and Lu, C. Y. (2003). Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase. J. Am. Soc. Nephrol. 14, 389-396.
30. Kris-Etherton, P. M., Harris, W. S., and Appel, L. J., and American Heart Association. Nutrition Committee. (2002). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747-2757.
31. Leaf, A. (1990). Cardiovascular effects of fish oils. Beyond the platelet. Circulation 82, 624-628.
32. Miida, T., Takahashi, A., and Ikeuchi, T. (2007). Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects. Pharmacol. Ther. 113, 378-393.
33. Moreira, E. L., de Oliveira, J., Nunes, J. C., Santos, D. B., Nunes, F. C., Vieira, D. S., Ribeiro-do-Valle, R. M., Pamplona, F. A., de Bem, A. F., Farina, M., et al. (forthcoming). Age-related cognitive decline in hypercholesterolemic LDL receptor knockout mice (LDLr-/-): Evidence of antioxidant imbalance and increased acetylcholinesterase activity in the prefrontal cortex. J. Alzheimers Dis.
34. Mozaffarian, D., and Rimm, E. B. (2006). Fish intake, contaminants, and human health: Evaluating the risks and the benefits. J. Am. Med. Assoc. 296, 1885-1899.
35. Munzel, T., Gori, T., Bruno, R. M., and Taddei, S. (2010). Is oxidative stress a therapeutic target in cardiovascular diseaseö Eur. Heart J. 31, 2741-2748.
36. Murata, K., Weihe, P., Budtz-Jørgensen, E., Jørgensen, P. J., and Grandjean, P. (2004). Delayed brainstem auditory evoked potential latencies in 14-year-old children exposed to methylmercury. J. Pediatr. 144, 177-183.
37. Myers, G. J., Marsh, D. O., Davidson, P. W., Cox, C., Shamlaye, C. F., Tanner, M., Choi, A., Cernichiari, E., Choisy, O., and Clarkson, T. W. (1995). Main neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from a maternal fish diet: Outcome at six months. Neurotoxicology 16, 653-664.
38. Ni, M., Li, X., Yin, Z., Sidoryk-We{ogonek}grzynowicz, M., Jiang, H., Farina, M., Rocha, J. B., Syversen, T., and Aschner, M. (2011). Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity. Glia 59, 810-820.
39. Ohno, M., Kishimoto, T., and Tada, M. (1995). The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets. Cell Biol. Toxicol. 11, 303-311.
40. Rissanen, T., Voutilainen, S., Nyyssöen, K., Lakka, T. A., and Salonen, J. T. (2000). Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: The Kuopio ischaemic heart disease risk factor study. Circulation 102, 2677-2679.
41. Rodrigues, L., Dutra, M. F., Ilha, J., Biasibetti, R., Quincozes-Santos, A., Leite, M. C., Marcuzzo, S., Achaval, M., and Gonölves, C. A. (2010). Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin. J. Neural Transm. 117, 1295-1305.
42. Salonen, J. T., Seppöen, K., Lakka, T. A., Salonen, R., and Kaplan, G. A. (2000). Mercury accumulation and accelerated progression of carotid atherosclerosis: A population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 148, 265-273.
43. Santos, D. B., Peres, K. C., Ribeiro, R. P., Colle, D., dos Santos, A. A., Moreira, E. L., Souza, D. O., Figueiredo, C. P., and Farina, M. (2012). Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice. Exp. Neurol. 233, 767-775.
44. Shoji, T., and Nishizawa, Y. (2006). Plasma lipoprotein abnormalities in hemodialysis patients-Clinical implications and therapeutic guidelines. Ther. Apher. Dial. 10, 305-315.
45. Silva, E. L., Moriel, P., Chang, Y. H., and Abdalla, D. S. (1995). Plasma antioxidant enzymes and oxidized lipoproteins in hypercholesterolemic rabbits. Biochem. Mol. Biol. Int. 36, 679-687.
46. Slotkin, T. A., Kavlock, R. J., Cowdery, T., Orband, L., Bartolome, M., Gray, J. A., Rehnberg, B. F., and Bartolome, J. (1986). Functional consequences of prenatal methylmercury exposure: Effects on renal and hepatic responses to trophic stimuli and on renal excretory mechanisms. Toxicol. Lett. 34, 231-245.
47. Smith, K. L., and Guentzel, J. L. (2010). Mercury concentrations and omega-3 fatty acids in fish and shrimp: Preferential consumption for maximum health benefits. Mar. Pollut. Bull. 60, 1615-1618.
48. Tamashiro, H., Akagi, H., Arakaki, M., Futatsuka, M., and Roht, L. H. (1984). Causes of death in Minamata disease: Analysis of death certificates. Int. Arch. Occup. Environ. Health 54, 135-146.
49. Toimela, T. A., and Tahti, H. (1995). Effects of mercury, methylmercury and aluminium on glial fibrillary acidic protein expression in rat cerebellar astrocyte cultures. Toxicol. In Vitro 9, 317-325.
50. Wall, R., Ross, R. P., Fitzgerald, G. F., and Stanton, C. (2010). Fatty acids from fish: The anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr. Rev. 68, 280-289.
51. Ware, W. R. (2008). High cholesterol and coronary heart disease in younger men: The potential role of stress induced exaggerated blood pressure response. Med. Hypotheses 70, 543-547.
52. Yasutake, A., Nakano, A., Miyamoto, K., and Eto, K. (1997). Chronic effects of methylmercury in rats. I. Biochemical aspects. Tohoku J. Exp. Med. 182, 185-196.
53. Yoshizawa, K., Rimm, E. B., Morris, J. S., Spate, V. L., Hsieh, C. C., Spiegelman, D., Stampfer, M. J., and Willett, W. C. (2002). Mercury and the risk of coronary heart disease in men. N. Engl. J. Med. 347, 1755-1760.
54. Zadelaar, S., Kleemann, R., Verschuren, L., de Vries-Van der Weij, J., van der Hoorn, J., Princen, H. M., and Kooistra, T. (2007). Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler. Thromb. Vasc. Biol. 27, 1706-1721.
55. Zalups, R. K. (2000). Molecular interactions with mercury in the kidney. Pharmacol. Rev. 52, 113-143